SNOA Sonoma Pharmaceuticals Price Chart

Sonoma Pharmaceuticals Inc. - graphic logo of issuer SNOA

Sonoma Pharmaceuticals develops dermatological products while facing pricing pressure and patent threats, with the asset valued at 0.83. This price chart on GURU.Markets links these challenges to the development of the Microcyn antiseptic system for medical and household use. High capacity utilization and the regular upgrading of packaging lines without operational downtime ensure business stability.

Market Price: Sonoma Pharmaceuticals (SNOA) for 07/04/2022 - 11/18/2026

Sonoma Pharmaceuticals - analytical breakdowns and key metrics (SNOA)

- stock value and consensus price forecast:
Fundamental valuation:Sonoma Pharmaceuticals Inc.
Signature product of Sonoma Pharma

The price reflects the market equilibrium between supply and demand, mirroring the aggregate valuation of assets and the company's future cash flows. For Sonoma Pharmaceuticals (SNOA), price action serves as an indicator of the business's sensitivity to supply chain disruptions and regulatory risks, allowing investors to assess the extent to which geopolitical instability impacts the enterprise's market capitalization.